Expectant management of patent ductus arteriosus for preterm infants: A meta-analysis of randomized controlled trials

被引：5

作者：

Cheema, Huzaifa Ahmad ^{[1
,2
]}

Majeed, Zuhair ^{[1
]}

Hayat, Tajamal ^{[1
]}

Ahmed, Arslan ^{[2
]}

Tariq, Muhammad Haider ^{[2
]}

Shahid, Abia ^{[1
]}

Titus, Anoop ^{[3
]}

Minhas, Abdul Mannan Khan ^{[4
]}

Ijaz, Sardar Hassan ^{[5
]}

Ghelani, Sunil J. ^{[6
,7
]}

Kulkarni, Aparna ^{[8
]}

Dani, Sourbha S. ^{[5
]}

机构：

[1] King Edward Med Univ, Dept Cardiol, Lahore 54000, Punjab, Pakistan

[2] King Edward Med Univ, Dept Med, Lahore, Pakistan

[3] St Vincent Hosp, Dept Internal Med, Worcester, MA USA

[4] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS USA

[5] Lahey Hosp & Med Ctr, Beth Israel Lahey Hlth, Div Cardiovasc Med, Burlington, MA USA

[6] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA

[7] Harvard Med Sch, Dept Pediat, Boston, MA USA

[8] Donald & Barbara Zucker Sch Med, Childrens Heart Ctr, Cohen Childrens Med Ctr Northwell Hlth, New York, NY USA

来源：

AMERICAN HEART JOURNAL | 2023年 / 266卷

关键词：

D O I：

10.1016/j.ahj.2023.07.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We conducted this meta-analysis to compare expectant management of patent ductus arteriosus (PDA) with active treatment for PDA closure in preterm infants. Data from 7 randomized controlled trials (RCTs) showed that all-cause mortality and other clinical adverse outcomes did not differ between expectant management of PDA and active treatment. Future large-scale and double-blinded RCTs with a consistent definition for hemodynamically significant PDA, and focusing on clearly delineated high-risk subgroups or later selective treatment are needed to further evaluate the role of expectant management. (Am Heart J 2023;266:179-183.)

引用

页码：179 / 183

页数：5

共 50 条

[41] Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
Dani, Carlo
Lista, Gianluca
Bianchi, Silvia
Mosca, Fabio
Schena, Federico
Ramenghi, Luca
Zecca, Enrico
Vento, Giovanni
Poggi, Chiara
Leonardi, Valentina
Minghetti, Diego
Rosignoli, Maria Teresa
Calisti, Fabrizio
Comandini, Alessandro
Cattaneo, Agnese
Lipone, Paola
EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (03) : 807 - 816
[42] Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: A multicenter, randomized, controlled trial
Jegatheesan, Priya
Ianus, Vlad
Buchh, Basharat
Yoon, Grace
Chorne, Nancy
Ewig, Audrey
Lin, Emil
Fields, Scott
Moon-Grady, Anita
Tacy, Term
Milstein, Jay
Schreiber, Michael
Padbury, James
Clyman, Ronald
JOURNAL OF PEDIATRICS, 2008, 153 (02): : 183 - 189
[43] Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
Carlo Dani
Gianluca Lista
Silvia Bianchi
Fabio Mosca
Federico Schena
Luca Ramenghi
Enrico Zecca
Giovanni Vento
Chiara Poggi
Valentina Leonardi
Diego Minghetti
Maria Teresa Rosignoli
Fabrizio Calisti
Alessandro Comandini
Agnese Cattaneo
Paola Lipone
European Journal of Pediatrics, 2021, 180 : 807 - 816
[44] High-Dose Ibuprofen for Patent Ductus Arteriosus in Extremely Preterm Infants: A Randomized Controlled Study
Dani, C.
Vangi, V.
Bertini, G.
Pratesi, S.
Lori, I.
Favelli, F.
Ciuti, R.
Bandinelli, A.
Martano, C.
Murru, P.
Messner, H.
Schena, F.
Mosca, F.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (04) : 590 - 596
[45] Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis
Mitra, Souvik
Florez, Ivan D.
Tamayo, Maria E.
Aune, Dagfinn
Mbuagbaw, Lawrence
Veroniki, Areti-Angeliki
Thabane, Lehana
BMJ OPEN, 2016, 6 (07):
[46] Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
Coviello, Caterina
Tataranno, Maria Luisa
Corsini, Iuri
Leonardi, Valentina
Longini, Mariangela
Bazzini, Francesco
Buonocore, Giuseppe
Dani, Carlo
FRONTIERS IN PEDIATRICS, 2020, 8
[47] Echocardiographic parameters of patent ductus arteriosus in preterm infants
A. Khositseth
P. Nuntnarumit
P. Chongkongkiat
Indian Pediatrics, 2011, 48 : 773 - 778
[48] Percutaneous Closure of Patent Ductus Arteriosus in Preterm Infants
Rueda Nunez, Fernando
Avila Alvarez, Alejandro
Fernandez Trisac, Jose Luis
Abelleira Pardeiro, Cesar
REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (06): : 740 - 741
[49] Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus
Van Overmeire, B
Touw, D
Schepens, PJC
Kearns, GL
van den Anker, JN
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (04) : 336 - 343
[50] Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants
Dani, C
Bertini, G
Reali, MF
Murru, P
Fabris, C
Vangi, V
Rubaltelli, FF
ACTA PAEDIATRICA, 2000, 89 (11) : 1369 - 1374

← 1 2 3 4 5 →